New era of biologic therapeutics in atopic dermatitis. Expert Opin Biol Ther. 2013;13:549-61.Guttman-Yassky E, Dhingra N, Leung DY. New era of biologic therapeutics in atopic dermatitis. Expert opinion on biological therapy. 2013; 13(4):549-61. doi: 10.1517/14712598.2013.758708 PMID: ...
“This approval is a significant win for patients, offering a first-line biologic option when topical therapies are insufficient,” said Jonathan Silverberg, Associate Professor of Dermatology at The George Washington University School of Medicine and Health Sciences in Washington, DC and a key investi...
" says Dr. Fonacier. "People with AD have been frustrated by the limitations of existing treatments. We're very excited by the new medications which were developed based on better understanding ofatopic dermatitis. We expect additional therapies...
Translation of the immune response and intracellular signaling pathways for dermatological conditions Dermatological therapy is enhancing their potential field of action based on the new treatments using biological antibodies and new small oral molecules applied for inflammatory diseases, cutaneous cancer, and...
We classify the degree of innovation as first-in-indication, i.e., drugs for the treatment of a condition for which no approved medical treatments existed; first-in-class, i.e., drugs with a molecular mechanism of action that had not been used by previously approved medical treatments; and...
atopic dermatitis and other dermatoses. The Ortho Dermatologics portfolio also includes several leading medical device systems for aesthetic applications, such as skin tightening and resurfacing, laser hair removal and preventative therapeutic skin care treatments. More information can ...
"We are delighted to introduce Ebglyss as a new biologic treatment for Korean people with moderate to severe atopic dermatitis, addressing the high unmet medical need,” Elli Lilly Korea Immunology Business Unit Director Kim Tae-hyun said. “Following the approvals of IL-17A inhibitor Talz, JAK...
Adults and children 12 years of age and older with moderate to severe eczema (atopic dermatitis [AD])that did not respond to previous treatment and their eczema is not well controlled with other pills or injections, including biologic medicines, or the use of other pills or injections...
It is a nasal spray. While previous triptan treatments constrict blood vessels to reduce migraine pain, CGRPs work by blocking the receptors that cause inflammation. A spray can be an answer for patients who have nausea with their migraines and have difficulty keeping pills down. ...
Benzodiazepines: rapid and more effective in short term than other treatments, but tolerance and dependence make them genemlly unsuitable for regular treatment: may interfere with success of behavior thcrapy. Beta-blockers: useful if somatie symptoms of anxiety arc prominent but not severe (more ...